Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

about

Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.Periodontal herpesviruses: prevalence, pathogenicity, systemic risk.

P2860

Q37227140-710E212B-7125-4B5F-B295-A48B198AA346 Q38562419-ECEF75B0-EACE-4D52-B29B-D41D48B45EFC

P2860

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

Item

http://www.wikidata.org/entity/Q42207455

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@en

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@nl

type

Item

label

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@en

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@nl

prefLabel

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@en

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@nl

P1476

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

@en

P2093

Kátia Azevedo

http://www.w3.org/2001/XMLSchema#string

Larissa Santos

http://www.w3.org/2001/XMLSchema#string

Ledy Oliveira

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular diagnosis of Epstein-Barr virus-related diseases

Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma.

Epstein-Barr virus latent infection in vivo.

Molecular virology of Epstein-Barr virus.

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

Infectious mononucleosis and Epstein-Barr virus.

High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.

Synergism between HIV and other viruses in the mouth.

Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers

Cellular target genes of Epstein-Barr virus nuclear antigen 2.

P304

262-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/1806-9282.60.03.016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Licínio Esmeraldo Silva

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263741328

http://www.w3.org/2001/XMLSchema#string

P698

25004273

http://www.w3.org/2001/XMLSchema#string

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

about

P2860

P2860

Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698